IZEA, Inc. (IZEA Worldwide) — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2014; financial statements are unaudited. The filing identifies the registrant as IZEA, Inc.
Business context
IZEA operates social sponsorship marketplaces, connecting advertisers with creators who publish sponsored content. It launched the IZEA Exchange (IZEAx) in March 2014 and planned to migrate transactions from older platforms to IZEAx by the end of 2014. Revenue primarily comes from sponsored campaigns, with additional media advertising and service fees.
Financial performance
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $1.93 million | $1.57 million | $5.86 million | $4.67 million |
| Gross profit | $1.24 million | $1.07 million | $3.86 million | $2.82 million |
| Gross margin | 64% | 68% | 66% | 60% |
| Operating loss | $(1.56) million | $(0.65) million | $(3.47) million | $(2.05) million |
| Net income (loss) | $0.69 million | $(0.98) million | $2.15 million | $(2.75) million |
| Operating EBITDA (non-GAAP) | $(1.31) million | $(0.14) million | $(2.75) million | $(1.22) million |
Revenue grew 23.4% in Q3 and 25.5% for the nine-month period. Growth was led by sponsored campaigns; management attributed it to larger managed campaigns and repeat customers. For the nine months, gross margin improved, which management linked to larger managed advertisers and service fees; Q3 margin declined as premium creators increased campaign costs.
Operating expenses rose 63.0% in Q3 and 50.5% year to date, reflecting higher personnel, marketing, promotional, platform-development and related costs. Net income principally reflects non-cash gains from remeasuring warrant and other derivative liabilities: $2.25 million in Q3 and $5.63 million for the nine months. Operating losses and negative Operating EBITDA show that this reported profit did not reflect profitable core operations.
Cash, liquidity and capital structure
- Cash was $7.88 million at September 30, 2014, versus $0.53 million at December 31, 2013. Working capital was approximately $7.70 million, based on reported current assets and current liabilities.
- Nine-month operating cash use was $3.27 million; investing cash use was $0.38 million; financing provided $11.00 million. Financing was chiefly the 2014 private placement, which generated about $10.93 million net proceeds.
- Total liabilities were $7.80 million, including a $5.42 million warrant liability. Capital lease obligations totaled approximately $0.08 million. No notes payable were outstanding at September 30, and no advances were outstanding under the Bridge Bank facility.
- The February 2014 private placement raised $12.0 million gross through sale of 34.29 million shares and included warrants for up to 34.29 million additional shares. Common shares outstanding were 57.50 million at September 30 and November 11.
Changes, outlook and risks
- Management reported net bookings of $2.02 million in Q3, up approximately 8%, and $6.3 million for nine months, up approximately 18%. It expected bookings to support higher 2014 revenue than in 2013; this is not a quantified earnings or cash-flow forecast.
- Management stated that the private-placement proceeds provided sufficient cash reserves for the foreseeable future, while also reporting a history of losses, accumulated deficit of $23.98 million and continued negative operating cash flow.
- IZEAx remained in public beta. The planned migration from older platforms and continued platform investment carry execution and commercial-adoption risks. Management also expected personnel and related costs to increase as sales efforts and platform development continued.
- Warrant fair values are sensitive to stock price and other market assumptions and can materially affect reported earnings. The company cautioned that a stock-price increase could increase the warrant liability and produce a loss; a decrease could produce a gain.
- Potential dilution is substantial: the filing cited outstanding options, warrants and unissued restricted shares, and warned that registered resale shares and warrant anti-dilution provisions could pressure the stock or dilute holders.
- Blue Calypso alleged patent infringement and sought unspecified damages. The case was stayed pending PTAB review of five asserted patents; the company said it could not estimate likelihood or potential exposure and intended to defend the case. A final PTAB decision was expected by year-end 2014.
- Management reported effective disclosure controls as of September 30, 2014, with no material quarter changes to internal control over financial reporting. No material subsequent events were reported.
Important facts for investors to verify
- Whether IZEAx migration and adoption supported sustained revenue growth and improved operating performance after the public beta.
- Cash burn, liquidity needs and the reliability of management’s “foreseeable future” funding assessment.
- The warrant liability’s valuation assumptions and the extent to which fair-value gains or losses drive reported net income.
- Actual and potential dilution from warrants, options, restricted shares, resale registrations and anti-dilution adjustments.
- Subsequent outcomes in the Blue Calypso patent proceedings and any resulting exposure.